Intraductal papillary mucinous neoplasm of the pancreas: A report of five cases with immunohistochemical findings

被引:13
作者
Kench, JG
Eckstein, RP
Smith, RC
机构
[1] WESTMEAD HOSP,DEPT TISSUE PATHOL,INST CLIN PATHOL & MED RES,SYDNEY,NSW,AUSTRALIA
[2] ROYAL N SHORE HOSP,DEPT PATHOL ANAT,SYDNEY,NSW,AUSTRALIA
[3] ROYAL N SHORE HOSP,DEPT SURG,SYDNEY,NSW,AUSTRALIA
关键词
pancreas; intraductal papillary mucinous tumor; mucinous ductal ectasia; p53; protein;
D O I
10.1080/00313029700169454
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Five cases of intraductal papillary-mucinous neoplasm (IPMN) of the pancreas are here described. This group of tumors represents a distinct clinicopathological entity with characteristic endoscopic, radiological, gross and microscopic appearances. Our five cases all showed marked dilatation of the main pancreatic duct which contained mucin and papillary tumor, sometimes filling and sometimes lining the lumen. The papillae were lined by columnar epithelium showing varying degrees of dysplasia. In one case there was adjacent invasive adenocarcinoma. Immunohistochemical staining for p53 protein was strongly positive in a majority of cells in the three cases with severe epithelial dysplasia and in the invasive adenocarcinoma, while weaker staining in a minority of cells was seen in the remaining two cases. A small proportion of tumor cells expressed PCNA and Ki-67 immunohistochemically in four cases, while the case with severe dysplasia and invasive carcinoma showed positivity for these proliferation markers in most cells. The four cases of exclusively intraductal tumor showed no evidence of disease recurrence at follow-up (median 55 months). The patient with IPMN and associated invasive adenocarcinoma died 21 months post-operatively. In view of its relatively favourable prognosis, it is important that IPMN is recognised.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 30 条
[1]  
FURUTA K, 1992, CANCER, V69, P1327, DOI 10.1002/1097-0142(19920315)69:6<1327::AID-CNCR2820690605>3.0.CO
[2]  
2-N
[3]  
GOWN A, 1993, APPL IMMUNOHISTOCHEM, P93
[4]   P53 IN TUMOR PATHOLOGY - CAN WE TRUST IMMUNOHISTOCHEMISTRY - REVISITED [J].
HALL, PA ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1994, 172 (01) :1-4
[5]   FREQUENT K-RAS MUTATIONS AND ABSENCE OF P53 MUTATIONS IN MUCIN-PRODUCING TUMORS OF THE PANCREAS [J].
HOSHI, T ;
IMAI, M ;
OGAWA, K .
JOURNAL OF SURGICAL ONCOLOGY, 1994, 55 (02) :84-91
[6]   MUCIN-HYPERSECRETING CARCINOMA OF THE PANCREAS [J].
ITAI, Y ;
KOKUBO, T ;
ATOMI, Y ;
KURODA, A ;
HARAGUCHI, Y ;
TERANO, A .
RADIOLOGY, 1987, 165 (01) :51-55
[7]   DUCTECTATIC MUCINOUS CYSTADENOMA AND CYSTADENOCARCINOMA OF THE PANCREAS [J].
ITAI, Y ;
OHHASHI, K ;
NAGAI, H ;
MURAKAMI, Y ;
KOKUBO, T ;
MAKITA, K ;
OHTOMO, K .
RADIOLOGY, 1986, 161 (03) :697-700
[8]  
LONGNECKER DS, 1995, ARCH PATHOL LAB MED, V119, P197
[9]  
MILCHGRUB S, 1992, CANCER-AM CANCER SOC, V69, P651, DOI 10.1002/1097-0142(19920201)69:3<651::AID-CNCR2820690309>3.0.CO
[10]  
2-#